1. Home
  2. SVM vs IRON Comparison

SVM vs IRON Comparison

Compare SVM & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercorp Metals Inc.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$9.55

Market Cap

2.2B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$76.54

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
IRON
Founded
N/A
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
SVM
IRON
Price
$9.55
$76.54
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$10.50
$103.18
AVG Volume (30 Days)
4.0M
813.6K
Earning Date
05-25-2026
05-07-2026
Dividend Yield
0.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.87
N/A
Revenue Next Year
$35.34
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$40.00
52 Week High
$15.77
$99.50

Technical Indicators

Market Signals
Indicator
SVM
IRON
Relative Strength Index (RSI) 38.98 60.12
Support Level $8.78 $70.29
Resistance Level $13.29 $82.70
Average True Range (ATR) 0.55 3.35
MACD -0.08 0.53
Stochastic Oscillator 29.73 55.59

Price Performance

Historical Comparison
SVM
IRON

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: